Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-05910-w ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Hematology, 2024. Verfasst von Xiaoli Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Soochow Hopes Hematonosis Hospital, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Anemia, Aplastic, Benzoates, Pyrazoles, Hydrazines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Innovation Capability Development Project of Jiangsu Province, Jiangsu Provincial Key Medical Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Soochow Hopes Hematonosis Hospital, Suzhou, Jiangsu, China.
- Department of Hematology, Longyan First Hospital, Affiliated to Fujian Medical University, Longyan, Fujian, China.
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzh…
- Department of Hematology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, Jiangsu, China.
- Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Förderung
- National Key Research and Development Program of China
- Innovation Capability Development Project of Jiangsu Province
- Jiangsu Provincial Key Medical Center
- Jiangsu Medical Outstanding Talents Project
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Science Foundation of Suzhou
Zitieren
APA
Li, X., Shangguan, X., Wang, H., Wang, Q., Zhang, Y., Han, B., Liu, R., Zhang, F., Fu, R., Lin, Z., Miao, M., Ma, X., Lei, M., Wu, D., & Liu, L. (2024). Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence. Annals of Hematology. https://doi.org/10.1007/s00277-024-05910-w
Vancouver
Li X, Shangguan X, Wang H, Wang Q, Zhang Y, Han B, et al. Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence. Annals of Hematology. 2024. doi:10.1007/s00277-024-05910-w
BibTeX
@article{Li2024,
author = {Li, Xiaoli and Shangguan, Xiaohui and Wang, Hong and Wang, Qingyuan and Zhang, Yanming and Han, Bing and Liu, Rongrong and Zhang, Fengkui and Fu, Rong and Lin, Zenghua and Miao, Miao and Ma, Xiao and Lei, Meiqing and Wu, Depei and Liu, Limin},
title = {Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-05910-w}
}
EUVIMED